The FDA has announced a proposal to ban most powdered gloves in the United States, which would effectively remove them from the marketplace, according to a press release issued by the agency.While the FDA acknowledged that use of the gloves is decreasi…
Author: Healio ophthalmology
Valeant announces CEO succession plan, financial update
Valeant Pharmaceuticals International announced in a press released that it has initiated a search for a new CEO to succeed J. Michael Pearson and has made changes to its board of directors.Pearson will continue to serve as CEO and a director until a r…
Alimera reports 167% increase in net revenue in 2015
Alimera Sciences reported $22.4 million in consolidated net revenue in 2015, a 167% increase from $8.4 million reported in 2014, according to a press release.Consolidated net revenue was reported at $5.8 million in the fourth quarter, a 241% increase f…
VIDEO: Phacoemulsification helpful technique in treating angle-closure glaucoma
At OSN New York, Reay H. Brown, MD, shares how he used phacoemulsication to treat three different cases of patients with angle-closure glaucoma.
VIDEO: Preoperative evaluation of dry eye disease in cataract patients
At OSN New York, Marguerite McDonald, MD, FACS, discusses the preoperative evaluation and management of dry eye disease in cataract patients.
VIDEO: Update in macular therapeutics
At OSN New York, Andrew A. Moshfeghi, MD, MBA, highlights new developments in retinal diseases in 2015.
VIDEO: OCT in the management of retinal diseases
At OSN New York, Jorge A. Fortun, MD, gives an overview of the advantages of using optical coherence tomography in the management retinal diseases.
VIDEO: Surgeon gives overview on MIGS
At OSN New York, Savak “Sev” Teymoorian, MD, MBA, gives an overview of minimally invasive glaucoma surgery and shares three different MIGS techniques.
VIDEO: Preparing the ocular surface for cataract, refractive surgery
At OSN New York, Jodi Luchs, MD, FACS, shares tips on how to avoid the consequences of having patients with untreated ocular surface disease before undergoing cataract/refractive surgery.
VIDEO: Advances, techniques for the artificial iris
At OSN New York, Nicole R. Fram , MD, discusses the technological advances of the artificial iris.
Novel ocular insert maintains lowered IOP in patients with open-angle glaucoma or ocular hypertension
FORT LAUDERDALE, Fla. — A novel bimatoprost insert can provide IOP reduction for up to 13 consecutive months in patients with open-angle glaucoma or ocular hypertension, according to mid-term data of an open-label extension study presented here.IOP was reduced 4 mm Hg to 5 mm Hg in patients included in the study, an extension of a phase 2 clinical trial that looked at efficacy and safety of the novel bimatoprost insert, Kuldev Singh, MD, told colleagues at the American Glaucoma Society meeting, where he delivered the presentation in place of (Read more...)
Abnormal dark adaptation potential early marker of macular dysfunction in cataract surgery candidates
PHILADELPHIA — Abnormal dark adaptation is a potential marker of subclinical macular dysfunction among patients who are otherwise deemed good candidates for multifocal IOL implantation, according to a presentation here. “In early [age-related macular degeneration], Snellen visual acuity is frequently undisturbed, but problems with night vision and vision in low-light conditions are frequently reported by patients.” Marta McKeague, MD, said at the Wills Eye Alumni Conference. The symptoms are similar to cataract symptoms, making it important to differentiate between the two, she added.
At 1 year, Raindrop inlay yields improvement in near, intermediate visual performance
The Raindrop near vision inlay yielded significant improvements in near and intermediate visual acuity in patients with emmetropic presbyopia, according to a study. The prospective FDA investigational device exemption clinical trial included 373 eyes f…
ThromboGenics enters into exclusive licensing agreement with Galapagos
ThromboGenics has signed an exclusive licensing agreement with Galapagos to develop and commercialize integrin antagonists to treat diabetic eye disease, according to a press release. ThromboGenics will pay a 1 million upfront technology transfer payment to Galapagos, and Galapagos will receive development and commercial milestone payments and royalties based on any future net sales from products that originated from Galapagos’ library of integrin antagonists.
VIDEO: Follow-up care software increases patient satisfaction
At OSN New York, John A. Hovanesian, MD, FACS, discusses how the use of follow-up care software in the ophthalmic practices can increase patient satisfaction.
VIDEO: Customized femtosecond laser fragmentation reduces phacoemulsification time
At OSN New York, P. Dee Stephenson, MD, FACS, discusses how customized femtosecond laser fragmentation can further reduce phacoemulsification time over standard femtosecond laser fragmentation.
VIDEO: Use of imaging technology for the management of diabetic retinopathy
At OSN New York, Andrew A. Moshfeghi, MD, talks about the evolution of retinal imaging.
Femtosecond laser cataract surgery, manual phaco yield similar results in residents’ hands
PHILADELPHIA — Femtosecond laser-assisted cataract surgery and manual phacoemulsification performed by ophthalmology residents yielded similar complication rates and visual and refractive outcomes, according to a study presented here.Wills Eye Hospital is the first ophthalmic residency program in the U.S. to incorporate femtosecond laser-assisted cataract surgery during training, Faheem Ahmed, MD, said at the Wills Eye Alumni Conference.
Glaukos reports 57% increase in net sales in 2015
Glaukos reported net sales of $71.7 million in 2015, a 57% increase from $45.6 million reported in 2014, according to a press release. Net sales in the fourth quarter were reported at $20.3 million, a 44% increase from $14.1 million reported in the sam…
See you soon at APAO 2016 Taipei
By downloading the Congress app from the app store, you will be able to access the latest information about the 31st APAO Congress. We have made it easy for everyone to download our Congress app — just scan the QR code on the final program book cover. You can leave that weighty volume in your hotel room once you have downloaded the app. It has everything you want from the final program book. Additionally, it shows real-time updates of the scientific program schedule and allows you to conduct a quick (Read more...)